Ubs Group Ag Omega Therapeutics, Inc. Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.75 - $1.45 $120,684 - $233,322	160,912 Added 5378.07%	163,904 $122,000
Q3 2024 Nov 14, 2024	BUY	$1.22 - $2.25 $1,884 - $3,476	1,545 Added 106.77%	2,992 $3,000
Q2 2024 Aug 13, 2024	SELL	$1.86 - $3.2 $48,849 - $84,041	-26,263 Reduced 94.78%	1,447 $2,000
Q1 2024 May 13, 2024	BUY	$2.73 - $5.32 $270 - $526	99 Added 0.36%	27,710 $101,000
Q4 2023 Feb 09, 2024	BUY	$1.35 - $3.21 $19,561 - $46,512	14,490 Added 110.43%	27,611 $83,000
Q3 2023 Nov 09, 2023	SELL	$2.15 - $5.68 $4,125 - $10,899	-1,919 Reduced 12.76%	13,121 $28,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $61,521 - $106,124	10,986 Added 270.99%	15,040 $84,000
Q1 2023 May 12, 2023	BUY	$4.81 - $10.95 $11,592 - $26,389	2,410 Added 146.59%	4,054 $24,000
Q4 2022 Feb 08, 2023	SELL	$4.22 - $7.05 $8,271 - $13,818	-1,960 Reduced 54.38%	1,644 $9,000
Q3 2022 Nov 10, 2022	BUY	$3.63 - $6.65 $13,082 - $23,966	3,604 New	3,604 $20,000
Q2 2022 Aug 10, 2022	SELL	$2.01 - $7.19 $596 - $2,135	-297 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.24 - $14.04 $9,079 - $20,428	-1,455 Reduced 83.05%	297 $2,000
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $8,701 - $22,563	768 Added 78.05%	1,752 $20,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $15,744 - $22,149	984 New	984 $19,000

1.51M

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $957K
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.